First Ever Rare Liver Disease Patient Cured with Personalized Gene Therapy Treatment – Pediatric and Rare Liver Diseases News
Kristin Hatcher, Director of our Pediatric and Rare Liver Diseases Program, joined global leaders and the GLI team at the EASL Congress this May to elevate the conversation around rare liver diseases.
Together for Better Liver Health: WHA78 Side Event Unites Global Stakeholders to Strengthen Public Health Responses to Metabolic Disease
Global health leaders call for urgent, integrated action on the rising rates of metabolic liver disease during a high-level policy event held on the sidelines of the 78th World Health Assembly and co-hosted by Global Liver Institute (GLI), the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD).
Global Health Leaders Convene at WHA78 Side Event to Advocate for Steatotic Liver Disease as a Core Non-Communicable Disease
Leading health organizations, policymakers, and public health advocates will come together during the 78th World Health Assembly (WHA78) for a pivotal side event titled “Together for Better Liver Health – Strengthening Public Health Responses to Metabolic Disease”.
The Frontline Role of Primary Care in Hepatitis B Care
Chronic infection of the liver by hepatitis B virus (HBV) remains a significant public health concern in the U.S. and around the world, particularly among at-risk populations.
Congress returns with budget reconciliation at the top of the to-do list. – Liver Health Policy Update
Key House authorizing committees are slated to kick off markups on their respective budget reconciliation instructions that will be combined into a single reconciliation bill.